Ideas

Combinatorial therapy for prostate cancer:  A therapeutic mix encompassing Calcitriol, Mitoxantrone, Despiramine, 17-DMAG, Salinomycin, Lovastatin, and Jasmonate (CMDDSLJ) inhibits the expression of mTORC1 and its downstream target AMD1, dismantles mTORC1-AMD1 signaling network, decreases polyamine levels, and inhibits prostate cancer progression via up regualtion of its target gene, 23/November/2017, 12.15 pm
Combinatorial therapy for prostate cancer:  A therapeutic mix encompassing Calcitriol, Mitoxantrone, Despiramine, 17-DMAG, Salinomycin, Lovastatin, and Jasmonate (CMDDSLJ) inhibits the expression of mTORC1 and its downstream target AMD1, dismantles mTORC1-AMD1 signaling network, decreases polyamine levels, and inhibits prostate cancer progression via up regualtion of its target gene, 23/November/2017, 12.15 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from CIC bioGUNE (Center for Cooperative Research in Biosciences), Bizkaia Technology Park, 801 Building, 48160 Derio, Spain shows that “mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.” This…

read more

Natural product-based combinatorial therapy for Lifespan extension: A therapeutic mix encompassing  Safrnal, Catalpol, Cholecalciferol, Maresin, Ursolic acid, DIM, Isoliquiritigenin, & Lutein   (SCCMUDIL) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via up regulation of its target gene ATG5 (Autophagy related 5), 23/Novem ber/2017, 7.40 am
Natural product-based combinatorial therapy for Lifespan extension: A therapeutic mix encompassing  Safrnal, Catalpol, Cholecalciferol, Maresin, Ursolic acid, DIM, Isoliquiritigenin, & Lutein   (SCCMUDIL) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via up regulation of its target gene ATG5 (Autophagy related 5), 23/Novem ber/2017, 7.40 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was published, in the online…

read more

Molecular therapy for glioblastoma: A therapeutic mix encompassing Temozolomide (TMZ), 17-AAG, Simvastatin, Salinomycin, Linalool, Amitriptyline (TASSLA) inhibits the expression of JMJD6, impairs functioning of transcription elongation machinery, inhibits the proliferation of glioblastoma cells, suppresses tumor cell migration, reduces metastasis and prolongs survival via down regulation of its target gene, 22/November/2017, 6.06 am
Molecular therapy for glioblastoma: A therapeutic mix encompassing Temozolomide (TMZ), 17-AAG, Simvastatin, Salinomycin, Linalool, Amitriptyline (TASSLA) inhibits the expression of JMJD6, impairs functioning of transcription elongation machinery, inhibits the proliferation of glioblastoma cells, suppresses tumor cell migration, reduces metastasis and prolongs survival via down regulation of its target gene, 22/November/2017, 6.06 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Ohio, USA shows that “Transcription elongation factors represent in vivo cancer…

read more

Natural product-derived combinatorial therapy for therapy-resistant cancers: A therapeutic mix encompassing encompassing   β-cryptoxanthin (BCX), Sodium butyrate, Fucoxanthin, Ganetespib, Rosuvastatin and Cyclophosphamide (BCXSFGRC) inhibits the expression of phospholipid glutathione peroxidase (GPX4), inhibits GPX4 signaling network and lipid peroxidase pathway, suppresses EMT protein ZEB1, increases sensitivity to anticancer therapy and prolongs survival via up regulation of its target gene, 21/November/2017, 10.49 pm
Natural product-derived combinatorial therapy for therapy-resistant cancers: A therapeutic mix encompassing encompassing   β-cryptoxanthin (BCX), Sodium butyrate, Fucoxanthin, Ganetespib, Rosuvastatin and Cyclophosphamide (BCXSFGRC) inhibits the expression of phospholipid glutathione peroxidase (GPX4), inhibits GPX4 signaling network and lipid peroxidase pathway, suppresses EMT protein ZEB1, increases sensitivity to anticancer therapy and prolongs survival via up regulation of its target gene, 21/November/2017, 10.49 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Broad Institute, Cambridge, Massachusetts, USA, Howard Hughes Medical Institute, Chevy Chase, Maryland and Department of Chemistry and Chemical Biology, Harvard University, Oxford St., Cambridge,…

read more

Life-extension therapy: Licorine, isolated from Clivia Miniata, Lycoris  (surprise lilies), and Narcissus, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 21/November/2017, 7.43 am
Life-extension therapy: Licorine, isolated from Clivia Miniata, Lycoris  (surprise lilies), and Narcissus, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 21/November/2017, 7.43 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1…

read more

Natural product therapy for pulmonary arterial hypertension: Enoxolone (also known as glycyrrhetinic acid) , one of the main components of Liquorice, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 21/November/2017, 12.41 am
Natural product therapy for pulmonary arterial hypertension: Enoxolone (also known as glycyrrhetinic acid) , one of the main components of Liquorice, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 21/November/2017, 12.41 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:   A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published, in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General…

read more
Start Typing